ATE208766T1 - (2-morpholinylmethyl)benzamid-derivate - Google Patents

(2-morpholinylmethyl)benzamid-derivate

Info

Publication number
ATE208766T1
ATE208766T1 AT96916121T AT96916121T ATE208766T1 AT E208766 T1 ATE208766 T1 AT E208766T1 AT 96916121 T AT96916121 T AT 96916121T AT 96916121 T AT96916121 T AT 96916121T AT E208766 T1 ATE208766 T1 AT E208766T1
Authority
AT
Austria
Prior art keywords
6alkyl
hydrogen
alk
amino
6alkyloxy
Prior art date
Application number
AT96916121T
Other languages
English (en)
Inventor
Daele Georges Henri Paul D Van
Den Keybus Frans Maria Alf Van
Marc Gustaaf Celine Verdonck
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Application granted granted Critical
Publication of ATE208766T1 publication Critical patent/ATE208766T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/30—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT96916121T 1995-05-23 1996-05-15 (2-morpholinylmethyl)benzamid-derivate ATE208766T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP95201350 1995-05-23
PCT/EP1996/002141 WO1996037486A1 (en) 1995-05-23 1996-05-15 (2-morpholinylmethyl)benzamide derivatives

Publications (1)

Publication Number Publication Date
ATE208766T1 true ATE208766T1 (de) 2001-11-15

Family

ID=8220318

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96916121T ATE208766T1 (de) 1995-05-23 1996-05-15 (2-morpholinylmethyl)benzamid-derivate

Country Status (18)

Country Link
US (1) US6100262A (de)
EP (1) EP0827500B1 (de)
JP (1) JPH11505815A (de)
KR (1) KR100446099B1 (de)
AT (1) ATE208766T1 (de)
AU (1) AU710037B2 (de)
CA (1) CA2220140C (de)
DE (1) DE69617001T2 (de)
DK (1) DK0827500T3 (de)
ES (1) ES2167563T3 (de)
IL (1) IL118379A (de)
MY (1) MY117938A (de)
NO (1) NO309900B1 (de)
NZ (1) NZ309065A (de)
PT (1) PT827500E (de)
TW (1) TW505639B (de)
WO (1) WO1996037486A1 (de)
ZA (1) ZA964100B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL155093A0 (en) 2000-09-29 2003-10-31 Glaxo Group Ltd Morpholin-acetamide derivatives for the treatment on inflammatory diseases
UA77515C2 (en) * 2002-04-04 2006-12-15 Diazabicyclo alkane derivatives possessing neuroldnin-nk1 receptor antagonistic activity
TWI423967B (zh) * 2008-02-21 2014-01-21 Dainippon Sumitomo Pharma Co 醯胺衍生物及含有其之醫藥組合物
MD3762368T2 (ro) 2018-03-08 2022-07-31 Incyte Corp Compuși diol aminopirazină ca inhibitori ai PI3K-Y
US11046658B2 (en) 2018-07-02 2021-06-29 Incyte Corporation Aminopyrazine derivatives as PI3K-γ inhibitors
CN110938068B (zh) * 2019-11-06 2022-12-23 广东东阳光药业有限公司 N-(吗啉-2-基甲基)酰胺衍生物及其用途

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ284687B6 (cs) * 1986-04-30 1999-02-17 Dainippon Pharmaceutical Co., Ltd. Substituovaný benzamidový derivát, způsob jeho výroby a farmaceutický prostředek na jeho bázi
EP0774460A1 (de) * 1994-03-30 1997-05-21 Yoshitomi Pharmaceutical Industries, Ltd. Benzosäurederivate und ihre medizinische verwendung

Also Published As

Publication number Publication date
ZA964100B (en) 1997-11-24
NO975342L (no) 1997-11-21
DK0827500T3 (da) 2002-02-25
IL118379A (en) 1999-12-31
WO1996037486A1 (en) 1996-11-28
TW505639B (en) 2002-10-11
NZ309065A (en) 1999-06-29
MY117938A (en) 2004-08-30
KR100446099B1 (ko) 2004-11-10
NO975342D0 (no) 1997-11-21
AU5899296A (en) 1996-12-11
DE69617001T2 (de) 2002-07-11
PT827500E (pt) 2002-04-29
CA2220140A1 (en) 1996-11-28
CA2220140C (en) 2008-02-12
NO309900B1 (no) 2001-04-17
DE69617001D1 (de) 2001-12-20
EP0827500A1 (de) 1998-03-11
IL118379A0 (en) 1996-09-12
EP0827500B1 (de) 2001-11-14
US6100262A (en) 2000-08-08
AU710037B2 (en) 1999-09-09
JPH11505815A (ja) 1999-05-25
KR19990008144A (ko) 1999-01-25
ES2167563T3 (es) 2002-05-16

Similar Documents

Publication Publication Date Title
AP1475A (en) Trisubstituted 1, 3, 5-triazine derivatives for treatment of HIV infections.
BG104738A (en) Hiv inhibiting pyrimidine derivatives
DK0590919T3 (da) Terapeutiske midler mod Parkinsons sygdom
NO920035L (no) Trifluormetylketon-derivater, og deres fremstilling og anvendelse
GB1058984A (en) Indolyl amides
GB1046506A (en) Guanidine compounds and process for their manufacture
IL106387A (en) Indole derivatives, their preparation and pharmaceutical compositions containing them
MY132062A (en) Apolipoprotein-b synthesis inhibitors
BG104717A (en) Water soluble azoles as broad-spectrum antifungals
SE8101464L (sv) 2-penem-3-karboxylsyraderivat, deras framstellning och anvendning
MY125562A (en) Hexahydro-pyrido (4,3-b) indole derivatives as antipsychotic drugs
DE69617001D1 (de) (2-morpholinylmethyl)benzamid-derivate
HUP9700955A2 (hu) Szubsztituált 2-naftoil-guanidin-származékok, előállításuk, valamint az e vegyületeket tartalmazó gyógyszerkészítmények
IL117980A (en) Triazolone derivatives their preparation and pharmaceutical compositions containing them useful for the treatment of hyperlipidemia
NO175097C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive hydrazoner
ES363527A1 (es) Procedimiento para la obtencion de derivados de las benza- zocinas.
CA2200579A1 (en) Phenyl-oxo-alkyl-(4-piperidinyl)benzoate derivatives as colon motility enhancing agents
MX9702356A (es) Derivados de fenil-oxo-alquil-(4-piperidinil)benzoato.
NO20010332L (no) Nye derivater av 6-deoksyerytromycin, deres fremstillingsprosess og deres anvendelse som medikamenter
ATE44741T1 (de) 2-(n-substituierte guanidino)-4heteroarylthiazole als mittel gegen geschwuere.
JO1648B1 (en) Nitrogen compounds
GB1013904A (en) Piperazinium salts and compositions containing them

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee